Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial

Volume
151
Pagination
309 - 318
DOI
10.1007/s10549-015-3397-0
Journal
BREAST CANCER RESEARCH AND TREATMENT
Issue
2
ISSN
0167-6806
Metadata
Show full item record
Authors
Mote, PA; Gompel, A; Howe, C; Hilton, HN; Sestak, I; Cuzick, J; Dowsett, M; Hugol, D; Forgez, P; Byth, K
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7627
Collections